Wisconsin
How Enright v. Eli Lilly & Co. applies in Wisconsin: state-specific rules, key cases, and bar exam notes for Other.
In Wisconsin, the principles from Enright v. Eli Lilly & Co. are utilized to evaluate product liability and causation in pharmaceutical cases. Wisconsin courts often follow the Restatement (Second) of Torts and consider reliable scientific evidence when determining the causation between a drug and alleged harm.
In Wisconsin, a plaintiff must demonstrate that the drug in question was unreasonably dangerous and that it caused the plaintiff's injury, applying standards set forth by the Restatement (Second) of Torts to evaluate evidence of causation.
The court held that the plaintiff must show that the product was defectively designed or manufactured to establish liability.
The court reinforced that for a product liability claim to prevail, the plaintiff needs to tie the defect of the product directly to the injuries sustained.
The court emphasized the need for expert testimony concerning causation when dealing with medical products and treatments.
Wisconsin's approach to product liability aligns closely with the federal standard under the Restatement (Second) of Torts, but Wisconsin may differ in its allowance for juries to weigh scientific evidence more liberally than some federal courts. Additionally, Wisconsin courts may focus on state-specific precedents that shape how evidence is evaluated.
Enright v. Eli Lilly & Co. is relevant for Wisconsin bar exam candidates focusing on tort law, especially in understanding the nuances of product liability and causation standards as they apply to pharmaceuticals.